Trial record 6 of 3300 for:    Louisville

Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03080974
Recruitment Status : Recruiting
First Posted : March 15, 2017
Last Update Posted : February 15, 2018
Information provided by (Responsible Party):
Robert C. Martin, University of Louisville

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 1, 2021
  Estimated Study Completion Date : April 1, 2022